Quantcast

Latest Cancer vaccine Stories

2014-02-02 23:00:43

MarketReportsOnline.com adds “US Cancer Vaccine Market Outlook 2018” report to its research store. US cancer vaccine market is expected to grow at a CAGR of 10% to surpass USD 20 billion by 2018. Dallas, Texas (PRWEB) February 02, 2014 Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines...

2014-01-29 16:28:12

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in) has announced the addition a new report "Drug Delivery in Cancer - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery remains a challenge in management of cancer. Approximately 12.5...

2014-01-13 12:26:52

WORCESTER, Mass. and TORONTO, Jan. 13, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced completion of enrollment of the Antigen Express, Inc. (www.antigenexpress.com) AE37 breast cancer immunotherapy trial. The clinical trial is designed to assess the ability of AE37 to reduce the risk of relapse in patients who have had breast cancer. While a pre-planned primary efficacy analysis is underway, completion of enrollment sets the...

2014-01-13 08:26:16

LOS ANGELES, Jan. 13, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today provided an update on the Company's anticipated 2014 corporate strategies and milestones. (Logo: http://photos.prnewswire.com/prnh/20140109/AQ43875LOGO) "2013 was an eventful year for ImmunoCellular Therapeutics," said Andrew Gengos, ImmunoCellular's Chief Executive Officer. "It was a year of progress, and some challenges - quite typical for a development-stage...

2014-01-09 12:26:33

BETHESDA, Md., Jan. 9, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for cancer, announced today that Linda Powers, CEO, will present at the Biotech Showcase(TM) 2014 Conference that is being held in San Francisco from January 13-15, 2014. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO) NW Bio's presentation will take place on Monday, January 13, at...

2014-01-09 12:26:12

Company Representatives will also attend the 32nd Annual J.P. Morgan Healthcare Conference next week in San Francisco WORCESTER, Mass. and TORONTO, Jan. 9, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, PhD, President of the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), will be a keynote speaker at IBC's 16(th) Annual TIDES Conference (www.IBCLifeSciences.com/Tides) to...

2014-01-08 16:26:14

FDA Study Aimed at Harnessing Immune System to Fight Tumors Now Available at All Five Hospital Sites CHICAGO, Jan. 8, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America® (CTCA), a leading provider of innovative cancer care for patients living with complex and advanced-stage disease, is now enrolling patients in an ovarian cancer vaccine clinical trial at all five of its hospital sites. CTCA Western Regional Medical Center (WRMC) in suburban Phoenix, Arizona and...

2014-01-07 12:28:59

Alex's Lemonade Stand Foundation Supports Cancer Vaccine Research at the University of Maryland. COLLEGE PARK, Md., Jan. 7, 2014 /PRNewswire-USNewswire/ -- In 2004, a form of cancer known as neuroblastoma claimed the life of Alexandra (Alex) Scott, a little girl who gained national attention for using her lemonade stand to raise money for cancer research. Now, the organization established in her memory, the Alex's Lemonade Stand Foundation (ALSF), has awarded University of Maryland...

2013-12-30 08:26:17

First European Patient In Trial Operated On In June, Profiled In BBC Report BETHESDA, Md., Dec. 30, 2013 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma...

2013-12-27 23:04:45

In response to an article published by Medical News Today (MNT), Voices Against Brain Cancer discusses a new brain tumor vaccine that is personalized to each patient. New York, NY (PRWEB) December 27, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Medical News Today that discusses a new brain cancer vaccine called HSPPC-96, which is personally molded to each patient’s genetic makeup. According to the...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related